Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001827506-24-000099
Filing Date
2024-11-07
Accepted
2024-11-07 17:21:31
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 a20241107forms-3shelfandat.htm S-3 481909
2 EX-1.2 exhibit12.htm EX-1.2 291857
3 EX-4.5 exhibit45.htm EX-4.5 314580
4 EX-4.8 exhibit48.htm EX-4.8 129648
5 EX-4.9 exhibit49.htm EX-4.9 132270
6 EX-4.10 exhibit410.htm EX-4.10 117593
7 EX-5.1 exhibit51.htm EX-5.1 34610
8 EX-23.1 exhibit231.htm EX-23.1 2207
9 EX-FILING FEES exhibit107.htm EX-FILING FEES 29525
10 imagea.jpg GRAPHIC 2048
11 image_0.jpg GRAPHIC 33844
  Complete submission text file 0001827506-24-000099.txt   1584914
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283078 | Film No.: 241437158
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)